Literature DB >> 16867995

Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures.

Mark C Wilkes1, Edward B Leof.   

Abstract

Transforming growth factor beta (TGF-beta) modulates a number of cellular phenotypes as divergent as growth stimulation and growth inhibition. Although the Smad pathway is critical for many of these responses, recent evidence indicates that Smad-independent pathways may also have a critical role. One such protein previously shown to regulate TGF-beta action independent of the Smad proteins is the c-Abl nonreceptor tyrosine kinase. In the current study we determined that TGF-beta receptor signaling activates c-Abl kinase activity in a subset of fibroblast but not epithelial cultures. This cell type-specific response occurs in a membrane-proximal locale independent of receptor internalization and upstream of dynamin action. Although c-Abl activation by TGF-beta is independent of Smad2 or Smad3, it is prevented by inhibitors of phosphatidylinositol 3-kinase or PAK2. Thus, c-Abl represents a target downstream of phosphatidylinositol 3-kinase-activated PAK2, which differentiates TGF-beta signaling in fibroblasts and epithelial cell lines and integrates serine/threonine receptor kinases with tyrosine kinase pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867995     DOI: 10.1074/jbc.M603721200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.

Authors:  Swati Bhattacharyya; Minghua Wu; Feng Fang; Warren Tourtellotte; Carol Feghali-Bostwick; John Varga
Journal:  Matrix Biol       Date:  2011-04-13       Impact factor: 11.583

2.  c-Abl silencing reduced the inhibitory effects of TGF-β1 on apoptosis in systemic sclerosis dermal fibroblasts.

Authors:  Elham Karimizadeh; Farhad Gharibdoost; Nasrin Motamed; Saeideh Jafarinejad-Farsangi; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Mol Cell Biochem       Date:  2015-04-16       Impact factor: 3.396

3.  TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.

Authors:  Anne Gingery; Elizabeth W Bradley; Larry Pederson; Ming Ruan; Nikki J Horwood; Merry Jo Oursler
Journal:  Exp Cell Res       Date:  2008-06-13       Impact factor: 3.905

Review 4.  The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.

Authors:  Tressa M Allington; William P Schiemann
Journal:  Cells Tissues Organs       Date:  2010-11-03       Impact factor: 2.481

5.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

6.  Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis.

Authors:  Joel Rosenbloom; Sergio A Jiménez
Journal:  Arthritis Rheum       Date:  2008-08

Review 7.  Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.

Authors:  Flavia V Castelino; John Varga
Journal:  Arthritis Res Ther       Date:  2010-08-23       Impact factor: 5.156

8.  Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.

Authors:  Mark C Wilkes; Claire E Repellin; Min Hong; Margarita Bracamonte; Sumedha G Penheiter; Jean-Paul Borg; Edward B Leof
Journal:  Dev Cell       Date:  2009-03       Impact factor: 12.270

9.  Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.

Authors:  Tressa M Allington; Amy J Galliher-Beckley; William P Schiemann
Journal:  FASEB J       Date:  2009-08-18       Impact factor: 5.191

10.  Abl kinase inhibits the engulfment of apoptotic [corrected] cells in Caenorhabditis elegans.

Authors:  Michael E Hurwitz; Pamela J Vanderzalm; Laird Bloom; Julia Goldman; Gian Garriga; H Robert Horvitz
Journal:  PLoS Biol       Date:  2009-04-28       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.